Cargando…

Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails

Being the primary sulfonamide among the most efficient zinc binding group (ZBG) to design inhibitors for the metallo-enzymes carbonic anhydrases (CA, EC 4.2.1.1), herein, we propose an investigation on four physiologically important human (h) CAs (hCA I, II, IV, and IX) with N(1)-substituted seconda...

Descripción completa

Detalles Bibliográficos
Autores principales: Awadallah, Fadi M., Bua, Silvia, Mahmoud, Walaa R., Nada, Hossam H., Nocentini, Alessio, Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009853/
https://www.ncbi.nlm.nih.gov/pubmed/29536779
http://dx.doi.org/10.1080/14756366.2018.1446432
_version_ 1783333474381332480
author Awadallah, Fadi M.
Bua, Silvia
Mahmoud, Walaa R.
Nada, Hossam H.
Nocentini, Alessio
Supuran, Claudiu T.
author_facet Awadallah, Fadi M.
Bua, Silvia
Mahmoud, Walaa R.
Nada, Hossam H.
Nocentini, Alessio
Supuran, Claudiu T.
author_sort Awadallah, Fadi M.
collection PubMed
description Being the primary sulfonamide among the most efficient zinc binding group (ZBG) to design inhibitors for the metallo-enzymes carbonic anhydrases (CA, EC 4.2.1.1), herein, we propose an investigation on four physiologically important human (h) CAs (hCA I, II, IV, and IX) with N(1)-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. The effect of the functionalisation of the sulfonamide group with five different substitution patterns, namely acetyl, pyridine, thiazole, pyrimidine, and carbamimidoyl, was evaluated in relation to the inhibition profile of the corresponding primary sulfonamide analogues. With most of these latter being nanomolar inhibitors of all four considered isoforms, a totally counterproductive effect on the inhibition potency can be ascribed to N(1)-functionalisations of the ZBG primary sulfonamide structure with pyridine, thiazole, and pyrimidine moieties. On the other hand, incorporation of less hindered groups, such as sulfonylacetamides and sulfonylguanidines, maintained a certain degree of activity dependent on the tailing moiety, with K(I)s spanning in the low micromolar range.
format Online
Article
Text
id pubmed-6009853
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-60098532018-07-11 Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails Awadallah, Fadi M. Bua, Silvia Mahmoud, Walaa R. Nada, Hossam H. Nocentini, Alessio Supuran, Claudiu T. J Enzyme Inhib Med Chem Research Paper Being the primary sulfonamide among the most efficient zinc binding group (ZBG) to design inhibitors for the metallo-enzymes carbonic anhydrases (CA, EC 4.2.1.1), herein, we propose an investigation on four physiologically important human (h) CAs (hCA I, II, IV, and IX) with N(1)-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. The effect of the functionalisation of the sulfonamide group with five different substitution patterns, namely acetyl, pyridine, thiazole, pyrimidine, and carbamimidoyl, was evaluated in relation to the inhibition profile of the corresponding primary sulfonamide analogues. With most of these latter being nanomolar inhibitors of all four considered isoforms, a totally counterproductive effect on the inhibition potency can be ascribed to N(1)-functionalisations of the ZBG primary sulfonamide structure with pyridine, thiazole, and pyrimidine moieties. On the other hand, incorporation of less hindered groups, such as sulfonylacetamides and sulfonylguanidines, maintained a certain degree of activity dependent on the tailing moiety, with K(I)s spanning in the low micromolar range. Taylor & Francis 2018-03-14 /pmc/articles/PMC6009853/ /pubmed/29536779 http://dx.doi.org/10.1080/14756366.2018.1446432 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Awadallah, Fadi M.
Bua, Silvia
Mahmoud, Walaa R.
Nada, Hossam H.
Nocentini, Alessio
Supuran, Claudiu T.
Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title_full Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title_fullStr Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title_full_unstemmed Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title_short Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
title_sort inhibition studies on a panel of human carbonic anhydrases with n1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009853/
https://www.ncbi.nlm.nih.gov/pubmed/29536779
http://dx.doi.org/10.1080/14756366.2018.1446432
work_keys_str_mv AT awadallahfadim inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails
AT buasilvia inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails
AT mahmoudwalaar inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails
AT nadahossamh inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails
AT nocentinialessio inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails
AT supuranclaudiut inhibitionstudiesonapanelofhumancarbonicanhydraseswithn1substitutedsecondarysulfonamidesincorporatingthiazolinoneorimidazoloneindoletails